JP2020531487A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531487A5 JP2020531487A5 JP2020510099A JP2020510099A JP2020531487A5 JP 2020531487 A5 JP2020531487 A5 JP 2020531487A5 JP 2020510099 A JP2020510099 A JP 2020510099A JP 2020510099 A JP2020510099 A JP 2020510099A JP 2020531487 A5 JP2020531487 A5 JP 2020531487A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022198545A JP2023021277A (ja) | 2017-08-23 | 2022-12-13 | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187519.8 | 2017-08-23 | ||
| EP17187519 | 2017-08-23 | ||
| PCT/EP2018/072785 WO2019038384A1 (en) | 2017-08-23 | 2018-08-23 | AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022198545A Division JP2023021277A (ja) | 2017-08-23 | 2022-12-13 | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020531487A JP2020531487A (ja) | 2020-11-05 |
| JPWO2019038384A5 JPWO2019038384A5 (https=) | 2022-10-20 |
| JP2020531487A5 true JP2020531487A5 (https=) | 2022-10-20 |
| JP7199738B2 JP7199738B2 (ja) | 2023-01-06 |
Family
ID=59686871
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510099A Active JP7199738B2 (ja) | 2017-08-23 | 2018-08-23 | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
| JP2022198545A Ceased JP2023021277A (ja) | 2017-08-23 | 2022-12-13 | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022198545A Ceased JP2023021277A (ja) | 2017-08-23 | 2022-12-13 | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11498919B2 (https=) |
| EP (2) | EP3672967B1 (https=) |
| JP (2) | JP7199738B2 (https=) |
| KR (1) | KR102731945B1 (https=) |
| CN (3) | CN116589461A (https=) |
| AU (1) | AU2018321135B2 (https=) |
| CY (1) | CY1124818T1 (https=) |
| DK (1) | DK3672967T3 (https=) |
| ES (1) | ES2902346T3 (https=) |
| HR (1) | HRP20211999T1 (https=) |
| HU (1) | HUE057818T2 (https=) |
| IL (3) | IL302355A (https=) |
| LT (1) | LT3672967T (https=) |
| PL (1) | PL3672967T3 (https=) |
| PT (1) | PT3672967T (https=) |
| RS (1) | RS62785B1 (https=) |
| SI (1) | SI3672967T1 (https=) |
| SM (1) | SMT202100718T1 (https=) |
| TW (2) | TW202325708A (https=) |
| WO (1) | WO2019038384A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7199738B2 (ja) * | 2017-08-23 | 2023-01-06 | スプリント バイオサイエンス アクティエボラーグ | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
| CA3200038A1 (en) * | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Anti-viral activity of vps34 inhibitors |
| WO2022115562A1 (en) | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154024B (it) * | 1982-09-22 | 1987-01-21 | Lepetit Spa | Derivati pridinici e procedimento per la loro produzione |
| WO2006127587A1 (en) | 2005-05-20 | 2006-11-30 | Vertex Pharmaceuticals Incorporated | Pyrrolopyridines useful as inhibitors of protein kinase |
| CN102143746A (zh) * | 2008-07-03 | 2011-08-03 | 埃克塞利希斯股份有限公司 | Cdk 调节剂 |
| CA2795422A1 (en) * | 2010-04-19 | 2011-10-27 | Abbvie Inc. | Pyrrolopyridine inhibitors of kinases |
| AU2011346567A1 (en) | 2010-12-21 | 2013-07-25 | Novartis Ag | Bi-heteroaryl compounds as Vps34 inhibitors |
| DK2655375T3 (en) | 2010-12-23 | 2015-03-09 | Sanofi Sa | PYRIMIDINON DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF |
| GB201120317D0 (en) | 2011-11-24 | 2012-01-04 | Queen Mary & Westfield College | Screening method |
| CN103450152B (zh) | 2012-06-04 | 2015-11-18 | 济南海乐医药技术开发有限公司 | 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物 |
| FR2992314B1 (fr) | 2012-06-22 | 2015-10-16 | Sanofi Sa | Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique |
| AU2015206652A1 (en) | 2014-01-14 | 2016-08-04 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2015108881A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| AU2017219846B2 (en) | 2016-02-19 | 2021-05-13 | Sprint Bioscience Ab | 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes |
| DK3416957T3 (da) | 2016-02-19 | 2020-09-21 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes |
| JP7199738B2 (ja) * | 2017-08-23 | 2023-01-06 | スプリント バイオサイエンス アクティエボラーグ | アザインドリルピリドンおよびジアザインドリルピリドン化合物 |
-
2018
- 2018-08-23 JP JP2020510099A patent/JP7199738B2/ja active Active
- 2018-08-23 US US16/638,727 patent/US11498919B2/en active Active
- 2018-08-23 SI SI201830500T patent/SI3672967T1/sl unknown
- 2018-08-23 CN CN202310536605.1A patent/CN116589461A/zh active Pending
- 2018-08-23 SM SM20210718T patent/SMT202100718T1/it unknown
- 2018-08-23 EP EP18759307.4A patent/EP3672967B1/en active Active
- 2018-08-23 AU AU2018321135A patent/AU2018321135B2/en not_active Ceased
- 2018-08-23 RS RS20211605A patent/RS62785B1/sr unknown
- 2018-08-23 PL PL18759307T patent/PL3672967T3/pl unknown
- 2018-08-23 CN CN201880054872.2A patent/CN111247144B/zh active Active
- 2018-08-23 IL IL302355A patent/IL302355A/en unknown
- 2018-08-23 ES ES18759307T patent/ES2902346T3/es active Active
- 2018-08-23 WO PCT/EP2018/072785 patent/WO2019038384A1/en not_active Ceased
- 2018-08-23 TW TW111140665A patent/TW202325708A/zh unknown
- 2018-08-23 TW TW107129491A patent/TWI785101B/zh not_active IP Right Cessation
- 2018-08-23 KR KR1020207006930A patent/KR102731945B1/ko active Active
- 2018-08-23 EP EP21196341.8A patent/EP4001278A1/en not_active Withdrawn
- 2018-08-23 LT LTEPPCT/EP2018/072785T patent/LT3672967T/lt unknown
- 2018-08-23 HR HRP20211999TT patent/HRP20211999T1/hr unknown
- 2018-08-23 PT PT187593074T patent/PT3672967T/pt unknown
- 2018-08-23 CN CN202310536658.3A patent/CN116589462A/zh active Pending
- 2018-08-23 HU HUE18759307A patent/HUE057818T2/hu unknown
- 2018-08-23 DK DK18759307.4T patent/DK3672967T3/da active
-
2020
- 2020-02-20 IL IL272792A patent/IL272792B/en unknown
-
2022
- 2022-01-03 CY CY20221100001T patent/CY1124818T1/el unknown
- 2022-04-25 IL IL292482A patent/IL292482B2/en unknown
- 2022-10-11 US US18/045,605 patent/US20230322772A1/en not_active Abandoned
- 2022-12-13 JP JP2022198545A patent/JP2023021277A/ja not_active Ceased